ARK Genomic Revolution Multi-Sector ETF

AMEX: ARKG
34.34+0.5200+1.54%Vol 89 7291Y Perf 9.92%
Jul 22nd, 2019 15:59
BID0.0000 ASK0.0000
Open33.92 Previous Close33.82
Price Range Ratio 52wk %
93.64 Managed Assets (in ths.)458 430

Today's Price Range

33.9234.44

52wk Range

21.9835.18

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral

The ARK Genomic Revolution Multi-Sector ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

Volume Overview
Volume89 729
Shares Outstanding (in ths.)13 555
Trades Count310
Dollar Volume2 734 051
Avg. Volume146 175
Avg. Weekly Volume103 915
Avg. Monthly Volume155 709
Avg. Quarterly Volume145 827
Dividends & Splits
Latest Dividend0.27
Dividend Date27th Dec 2018
Dividend Rate Ann.0.27
Dividend Yield Ann.0.80
Latest Split-
Split Date-
Fundamentals & Details
LeverageLong
Alpha5.34
Beta1.87
Standard Deviaton2.43
Managed Assets (in ths.)458 430
NAV33.82
First Trade Price20.32
PE Ratio28.06
Management Fee0.75
OptionsYes
Classification
Fund FamilyArk Funds
Underlying Index-
Asset ClassPortfolio Multi ...
RegionGlobal
Country-
FocusBiotech
Equity Index-
Leveraged Family-
Investment Strategy-
Equity Size-
Equity Style-
TypeBiotech
Inception Date4th Nov 2014
Alternative Asset Class-
Performance
1 Month
5.18%
3 Months
3.50%
6 Months
26.20%
1 Year
9.92%
3 Years
85.82%
5 Years
0.00%
10 Years
68.26%

Name / TickerPriceChg.Chg.%
ARKG34.340.52001.54
AAPL207.224.63002.29
GOOG1 138.077.97000.71
MSFT138.431.81001.32
XOM75.070.08000.11
WFC46.480.45000.98
JNJ128.64-1.6700-1.28
FB202.323.96002.00
GE10.210.17001.69
JPM114.270.73000.64
Top HoldingsTickerNamePosition
Total Holdings Count 34
Top 1NVTAInvitae Corporation10.11%
Top 2ILMNIllumina Inc.9.41%
Top 3NTLAIntellia Therapeutics Inc.7.16%
Top 4CRSPCRISPR Therapeutics AG6.75%
Top 5EDITEditas Medicine Inc.5.77%
Top 6VCYTVeracyte Inc.4.72%
Top 7TDOCTeladoc Health Inc.4.36%
Top 8IOVAIovance Biotherapeutics Inc.4.31%
Top 9NSTGNanoString Technologies Inc.4.22%
Top 10CLLSCellectis S.A.3.07%
Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

44%56%

Bearish Bullish

27%73%

Bearish Bullish

61%39%